Your search returned 2 results.

Results
	1.	Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. MedStar authors: Waksman, Ron Weissman, Neil J PMID: 23332165 Year: 2013 Citation: Lancet. 381(9869):836-44, 2013 Mar 9. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bose D, Degen H, Erbel R, Erne P, Haude M, Koolen J, Prati F, Verheye S, Vermeersch P, Waksman R, Weissman N, Wijnbergen I Add to cart (remove)
	2.	Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. MedStar authors: Waksman, Ron Weissman, Neil J PMID: 23339805 Year: 2013 Citation: Eurointervention. 8(9):1006-11, 2013 Jan 22. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Deleanu D, Dorobantu M, Hamon M, Niculescu R, Waksman R, Weissman NJ DOI: http://dx.doi.org/10.4244/EIJV8I9A155 Add to cart (remove)

Refine your search